AISAP Cardio vs DeepRhythmAI
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your clinical setting requires immediate, bedside cardiac diagnostic assessments for structural heart disease and heart failure. This tool is ideal for point-of-care scenarios where rapid evaluation of valvular pathologies, LVEF, and cardiac dimensions is crucial for early detection and intervention. It streamlines the process of obtaining comprehensive cardiac ultrasound reports directly at the patient's side.
View AISAP Cardio →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-powered analysis of ECG data for cardiac arrhythmia detection and classification. This solution is best suited for practices looking to significantly reduce missed diagnoses in ECG interpretation and streamline their reporting workflows, especially when dealing with large volumes of ECG data from various devices.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | DeepRhythmAI |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing information |
| Deployment | Cloud-based | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio focuses on providing rapid, comprehensive cardiac diagnostic assessments and measurements at the bedside, with automated generation of analyses, interpretations, and reports. This emphasis on point-of-care use and automated reporting suggests a highly streamlined and intuitive user experience for clinicians in a fast-paced environment.
Clinical Value
DeepRhythmAIBoth tools are FDA-cleared and offer significant clinical benefits in cardiac diagnostics. However, DeepRhythmAI explicitly quantifies its impact by claiming to reduce missed diagnoses by '14x to 114x fewer' and being trained on '250 billion+ annotated heartbeats,' providing a strong, data-backed claim of superior accuracy in arrhythmia detection.
Pricing & Value
TieBoth AISAP Cardio and DeepRhythmAI have non-transparent pricing, with details available only upon contact or listed as 'enterprise' without specifics. Without any public pricing information or comparative cost-benefit analyses, it is impossible to determine which offers better value.
Enterprise Readiness
DeepRhythmAIDeepRhythmAI, from Medicalgorithmics S.A., is offered by a more established company (founded 2005) with 'numerous healthcare providers globally' and explicitly provides an 'API available' and targets a broad 'Solo to large health systems' customer base. This indicates a more mature and adaptable enterprise solution compared to AISAP Cardio, which, while scalable and integrated, lacks these specific indicators of broad enterprise adoption and flexibility.
Innovation
DeepRhythmAIWhile AISAP Cardio innovates by bringing AI-powered interpretation to point-of-care ultrasound, DeepRhythmAI highlights the use of advanced AI models (CNN and Transformer) and an exceptionally large training dataset of '250 billion+ annotated heartbeats.' This suggests a higher degree of algorithmic sophistication and data-driven innovation in its core technology for ECG analysis.
Support & Docs
TieThe provided structured facts offer no information regarding support or documentation for either tool. While web searches indicate contact information for both companies, readily comparable public information on dedicated support portals, comprehensive documentation libraries, or training programs is not explicitly available for either product.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | DeepRhythmAI |
|---|---|---|
| Name | AISAP Cardio | DeepRhythmAI |
| Primary Use Case | Provides rapid, comprehensive cardiac diagnostic assessments and measurements from POCUS, enabling early detection of structural heart disease and heart failure at the bedside. | Revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. |
| Company | Aisap | Medicalgorithmics S.A. |
| Data Input Type | Point-of-care ultrasound (POCUS) | ECG data |
| Key Analytical Capabilities | AI-powered interpretation for early cardiac disease detection, assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), measurement of LVEF, right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | AI-powered arrhythmia detection and classification, utilizes CNN and Transformer models, trained on 250 billion+ annotated heartbeats. |
| Integration Capabilities | Vendor-agnostic and scalable solution; integration with existing clinical workflows, EHR/EMR, and PACS. | Device-agnostic and integrates with various ECG devices. |
| Specialties Served | Cardiology, Emergency Medicine, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and DeepRhythmAI.